BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 867313)

  • 1. [Mechanism of action of low doses of subcutaneous heparin (author's transl)].
    Duckert F
    Ther Umsch; 1977 May; 34(5):334-7. PubMed ID: 867313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin and antithrombin III (author's transl)].
    Kambayashi J; Chang SW; Ohno H; Kobayashi T; Kosaki G
    Rinsho Ketsueki; 1981 Jul; 22(7):1010-5. PubMed ID: 7328760
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of subcutaneous depot heparin on certain coagulation parameters (preliminary report)].
    Petö I; Blaskó G; Sas G
    Orv Hetil; 1981 Jan; 122(3):145-6. PubMed ID: 7220045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic action of "low doses" or "small doses" of heparin administered subcutaneously].
    Raby C; Bertrand H
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2476. PubMed ID: 693287
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose heparin therapy.
    Chamberlain SL
    Am J Nurs; 1980 Jun; 80(6):1115-7. PubMed ID: 6446861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of deep venous thrombosis after operation with low dose subcutaneous heparin (author's transl)].
    Ansay J; Fastrez R; Kutnowski M; Kraytman M
    Ann Chir; 1977 Mar; 31(3):263-7. PubMed ID: 900826
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prophylaxis of postoperative deep vein thromboses by means of weak doses of subcutaneous heparin (author's transl)].
    Kraytman M; Kutnowski M; Ansay J; Fastrez R
    Acta Chir Belg; 1976 Sep; 75(5):519-29. PubMed ID: 1015181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mode of action and control of "low dose heparin" (author's transl)].
    Bruhn HD; Albert JP; Petermann W
    Med Klin; 1977 Mar; 72(9):349-52. PubMed ID: 840146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombosis and heart infarct prevention using subcutaneous heparin therapy].
    Steger W
    Fortschr Med; 1974 Jan; 92(2):76-9. PubMed ID: 4818252
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low dosage of heparin. Theoretical and practical evaluation].
    Gormsen J; Feddersen C; Clausen NT
    Ugeskr Laeger; 1974 Apr; 136(16):865-70. PubMed ID: 4825561
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heparin in therapeutics (author's transl)].
    Capel P
    Rev Med Brux; 1981 Mar; 2(3):181-9. PubMed ID: 7015442
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of various doses and various applications of heparin on the fat metabolism and on blood coagulation.
    Losonczy H; Nagy I
    Wien Klin Wochenschr; 1984 Dec; 96(24):885-9. PubMed ID: 6528619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of a subcutaneously administered heparin preparation].
    Stosiek U; Grumbrecht C
    Med Welt; 1974 Apr; 25(17):765-8. PubMed ID: 4417187
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin therapy by continuous intravenous infusion.
    Swanson M; Cacace L
    Am J Hosp Pharm; 1971 Oct; 28(10):792-5. PubMed ID: 5125174
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of small doses of heparin in ischemic heart disease].
    Doroshenko GL
    Vrach Delo; 1973 Nov; 11():27-30. PubMed ID: 4786926
    [No Abstract]   [Full Text] [Related]  

  • 17. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
    Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM
    Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new route of heparin administration--the lung.
    Kavanagh LW; Jaques LB
    Arzneimittelforschung; 1976; 26(3):389-92. PubMed ID: 989334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response relationships of anticoagulant activities after subcutaneous administration of two low molecular weight heparins in healthy individuals.
    Hellstern P; Kiehl R; von Blohn G; Köhler M; Meierhenrich U; Wenzel E
    Thromb Haemost; 1986 Oct; 56(2):225-8. PubMed ID: 3810557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stability of the anticoagulating effect of calcium and sodium heparin, injected subcutaneously].
    Langer B; Pinto WC; Maia RA; Kwang WT; Leão LE
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):121-3. PubMed ID: 308244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.